Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed on April 23, 2018, by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares. The report covers the month of April 2018 and serves to furnish specific corporate announcements to the U.S. Securities and Exchange Commission.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover sheet for attached exhibits rather than a financial statement.
Material Changes
No material financial changes or comparative period data are detailed within the text of this Form 6-K. The filing references two external documents containing the substantive information:
- Exhibit 99.1: Press Release issued on April 22, 2018.
- Exhibit 99.2: Ad-hoc announcement according to Art. 17 (1) MAR issued on April 22, 2018.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be contained within the referenced press release and ad-hoc announcement.
Key Facts for Investor Verification
- Verify the content of the April 22, 2018, Press Release (Exhibit 99.1) for specific financial or operational updates.
- Review the Ad-hoc announcement (Exhibit 99.2) for regulatory disclosures required under the Market Abuse Regulation (MAR).
- Note that the filing is signed by CEO Rice Powell and CFO Michael Brosnan on behalf of the General Partner.